91ɬ

At event honouring 116 winners of major awards, keynote speaker and SSHRC Gold Medal recipient Myriam Denov emphasized the importance of listening.

91ɬ celebrated more than 100 researchers at the 21st edition of Bravo, a gala event May 7 honouring the winners of major provincial, national and international research prizes and awards in 2025.

Classified as: bravo gala
Published on: 14 May 2026

The 2026 cohort of Distinguished James 91ɬ Professors, James 91ɬ Professors and William Dawson Scholars embody ‘the very best of our academic community’.

Provost and Executive Vice-President (Academic) Angela Campbell has named 31 91ɬ professors as Distinguished James 91ɬ Professors, James 91ɬ Professors or William Dawson Scholars. The internal awards recognize exceptional research achievements.

Published on: 13 May 2026

From fundamental physics to child well-being, 91ɬ researchers advance discovery across disciplines

91ɬ has been awarded $18.1 million in federal funding to support 16 Canada Research Chairs – six new and 10 renewed.

Published on: 13 May 2026

Federal fund will support transformative high risk, high reward research across engineering, science, and medicine at 91ɬ.

Classified as: NFRF
Published on: 13 May 2026

Mallik Mahmud, Assistant Professor in the Department of Geography, is one of nine early-career ocean researchers across Canada awarded the by the Marine Environmental Observation Prediction and Response Network (MEOPAR), recognizing exceptional early-career ocean researchers whose work advances climate resilience.

Classified as: Department of Geography
Published on: 12 May 2026

Montreal, May 6, 2026– Researchers from 91ɬ have introduced a groundbreaking new class of molecules that could significantly reshape drug discovery and development. The technology, called Aptamer‑Like ENcoded OligoMERs (Alenomers), combines the advantages of antibodies and DNA‑based therapeutics while overcoming key limitations of both.

Published on: 7 May 2026

Montreal, May 6, 2026 – Researchers from 91ɬ have introduced a groundbreaking new class of molecules that could significantly reshape drug discovery and development. The technology, called Aptamer‑Like ENcoded OligoMERs (Alenomers), combines the advantages of antibodies and DNA‑based therapeutics while overcoming key limitations of both.

Classified as: Aptamers, DrugDiscovery, biotechnology, ChemicalBiology, TranslationalScience, TherapeuticDevelopment, D2R
Published on: 6 May 2026

Social Sciences and Humanities Research Council (SSHRC) awards $598,278 to five 91ɬ journals spanning disciplines from law to religion

Classified as: SSHRC
Published on: 30 Apr 2026

Montreal – April 29, 2026 | 91ɬ’s DNA to RNA Initiative (D2R) has invested nearly $6 million in funding to support four groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on April 23-24, 2026.

Classified as: D2R, DNA to RNA, TIR, Translational Research, funding
Published on: 29 Apr 2026

Projects focusing on MedTech and genomics cut across disciplines while mobilizing expertise at 91ɬ and other Quebec institutions to meet the challenges of today and tomorrow

Classified as: NSERC CREATE
Published on: 21 Apr 2026

In an effort to support researchers in incorporating the principles of Equity, Diversity, and Inclusion (EDI) into their work as RNA research, the D2R EDI Community of Practice is organizing an event to discuss and problem solve through common EDI mistakes in the context of RNA research. In this event, two speakers will share anecdotes on major EDI pitfalls they have encountered and strategies others can use to prevent them in the future. Together, we will discuss common pitfalls in a collaborative and low-pressure environment.

Published on: 16 Apr 2026

Have an innovative idea and not sure how the patenting process works? Join D2R and Lavery to learn how patent strategy supports scientific impact and how early choices impact downstream commercialization value when bringing life science innovations to market.

Designed to be accessible without sacrificing rigor, this session equips researchers and research administrators with a clearer understanding of how patent strategy supports scientific impact - and how early choices can materially affect downstream value and commercialization to bring life sciences innovations to market.

Classified as: training, Research, D2R, D2R Training Program
Published on: 15 Apr 2026

New funding fuels 91ɬ-led breakthroughs on how gut viruses influence childhood health and how engineered proteins can prevent damaging oral bacterial biofilms.

Published on: 14 Apr 2026

AReNA is launching a series offree webinarsdedicated toRNA therapies, spotlighting leading international companies to fuel innovation, inspire the local ecosystem, and create tangible collaboration opportunities.

The first webinar in this series focuses on one of the field’s most critical challenges:biomanufacturing.

Reinventing RNA biofabrication : fermentation, innovative vectors and new-generation delivery

Tuesday, April 24 from8:30 to 9:30 am, three companies present disruptive biofabrication technologies.

Published on: 10 Apr 2026

Pages

Back to top